Goldman Sachs Group Inc Axonics, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Axonics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 517,940 shares of AXNX stock, worth $36.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
517,940
Previous 419,656 23.42%
Holding current value
$36.8 Million
Previous $28.2 Million 27.9%
% of portfolio
0.01%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$67.3 - $69.67 $6.61 Million - $6.85 Million
98,284 Added 23.42%
517,940 $36.1 Million
Q2 2024

Aug 13, 2024
BUY
$66.47 - $69.65 $1.83 Million - $1.92 Million
27,505 Added 7.01%
419,656 $28.2 Million
Q1 2024

May 15, 2024
SELL
$56.67 - $69.36 $13 Million - $15.9 Million
-229,419 Reduced 36.91%
392,151 $27 Million
Q4 2023

Feb 13, 2024
BUY
$49.38 - $63.75 $1.99 Million - $2.57 Million
40,306 Added 6.93%
621,570 $38.7 Million
Q3 2023

May 14, 2024
SELL
$48.64 - $62.51 $1.96 Million - $2.52 Million
-40,306 Reduced 6.48%
581,264 $32.6 Million
Q3 2023

Nov 14, 2023
BUY
$48.64 - $62.51 $3.71 Million - $4.76 Million
76,185 Added 15.08%
581,264 $32.6 Million
Q2 2023

May 14, 2024
SELL
$47.99 - $60.21 $3 Million - $3.76 Million
-62,464 Reduced 11.01%
505,079 $25.5 Million
Q2 2023

Aug 14, 2023
SELL
$47.99 - $60.21 $3 Million - $3.76 Million
-62,464 Reduced 11.01%
505,079 $25.5 Million
Q1 2023

May 14, 2024
SELL
$52.6 - $67.34 $8.62 Million - $11 Million
-163,865 Reduced 22.4%
567,543 $31 Million
Q1 2023

May 11, 2023
SELL
$52.6 - $67.34 $8.62 Million - $11 Million
-163,865 Reduced 22.4%
567,543 $31 Million
Q4 2022

May 14, 2024
SELL
$59.56 - $76.6 $4.39 Million - $5.65 Million
-73,756 Reduced 9.16%
731,408 $45.7 Million
Q4 2022

Feb 13, 2023
SELL
$59.56 - $76.6 $4.39 Million - $5.65 Million
-73,756 Reduced 9.16%
731,408 $45.7 Million
Q3 2022

May 14, 2024
BUY
$57.96 - $78.12 $12.5 Million - $16.8 Million
214,889 Added 36.4%
805,164 $56.7 Million
Q3 2022

Nov 10, 2022
BUY
$57.96 - $78.12 $12.5 Million - $16.8 Million
214,889 Added 36.4%
805,164 $56.7 Million
Q2 2022

May 14, 2024
SELL
$39.5 - $64.42 $1.24 Million - $2.02 Million
-31,295 Reduced 5.03%
590,275 $33.5 Million
Q2 2022

Aug 15, 2022
BUY
$39.5 - $64.42 $1.07 Million - $1.74 Million
27,017 Added 4.8%
590,275 $33.5 Million
Q1 2022

May 16, 2022
SELL
$43.74 - $62.76 $5.13 Million - $7.35 Million
-117,172 Reduced 17.22%
563,258 $35.3 Million
Q4 2021

Feb 14, 2022
BUY
$50.01 - $73.35 $3.52 Million - $5.17 Million
70,478 Added 11.55%
680,430 $38.1 Million
Q3 2021

Nov 10, 2021
BUY
$59.21 - $78.66 $36.1 Million - $48 Million
609,952 New
609,952 $39.7 Million

Others Institutions Holding AXNX

# of Institutions
235
Shares Held
42.1M
Call Options Held
83.4K
Put Options Held
65.3K
View Full List

About Axonics, Inc.

AXNX Quotes by TradingView
  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email